Loading…

Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2006-07, Vol.45 (7), p.920-920
Main Authors: Liu, D. T. L., Chan, A. Y. K.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c363t-ec0ad4c2e0635be2a1d7c894451e5eac41cb0630243b8121fa230670f05736fa3
container_end_page 920
container_issue 7
container_start_page 920
container_title Rheumatology (Oxford, England)
container_volume 45
creator Liu, D. T. L.
Chan, A. Y. K.
description
doi_str_mv 10.1093/rheumatology/kel059
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_195666013</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1069184221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-ec0ad4c2e0635be2a1d7c894451e5eac41cb0630243b8121fa230670f05736fa3</originalsourceid><addsrcrecordid>eNpNkF1LwzAUhoMoTqe_QJDgfV3SNGnnjcj8mG6ooIPhTcjSU9etbWqSivv3dmxMr86B93nPgQehM0ouKemznp1DUypvCvO56i2hILy_h45oJMKAMBbu7_Yw6qBj5xaEEE5Zcog6VPCEJpQfoenEATYZzitv1TdUpnFYr3Rh6rlx9VyVeQptiP0ccG2hJXxuqnVDG1uBKnAJhb_Ci8b5PMshxcbiyvjrE3SQqcLB6XZ20eT-7n0wDMYvD4-Dm3GgmWA-AE1UGukQiGB8BqGiaayTfhRxChyUjqietREJIzZLaEgzFTIiYpIRHjORKdZFF5u7tTVfDTgvF6axVftS0j4XQhDKWohtIG2NcxYyWdu8VHYlKZFrmfK_TLmR2bbOt6ebWQnpX2drrwWCDZA7Dz-7XNmlFDGLuRxOP-RgNHp9Ht4-yTf2C8BmhNk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195666013</pqid></control><display><type>article</type><title>Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?</title><source>Oxford Journals Online</source><source>Alma/SFX Local Collection</source><creator>Liu, D. T. L. ; Chan, A. Y. K.</creator><creatorcontrib>Liu, D. T. L. ; Chan, A. Y. K.</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kel059</identifier><identifier>PMID: 16581815</identifier><identifier>CODEN: BJRHDF</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Arthritis, Rheumatoid - complications ; Corneal Ulcer - prevention &amp; control ; Cyclophosphamide - therapeutic use ; Humans ; Immunosuppressive Agents - therapeutic use ; Terminology as Topic</subject><ispartof>Rheumatology (Oxford, England), 2006-07, Vol.45 (7), p.920-920</ispartof><rights>Copyright Oxford University Press(England) Jul 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c363t-ec0ad4c2e0635be2a1d7c894451e5eac41cb0630243b8121fa230670f05736fa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16581815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, D. T. L.</creatorcontrib><creatorcontrib>Chan, A. Y. K.</creatorcontrib><title>Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology</addtitle><subject>Arthritis, Rheumatoid - complications</subject><subject>Corneal Ulcer - prevention &amp; control</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Terminology as Topic</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpNkF1LwzAUhoMoTqe_QJDgfV3SNGnnjcj8mG6ooIPhTcjSU9etbWqSivv3dmxMr86B93nPgQehM0ouKemznp1DUypvCvO56i2hILy_h45oJMKAMBbu7_Yw6qBj5xaEEE5Zcog6VPCEJpQfoenEATYZzitv1TdUpnFYr3Rh6rlx9VyVeQptiP0ccG2hJXxuqnVDG1uBKnAJhb_Ci8b5PMshxcbiyvjrE3SQqcLB6XZ20eT-7n0wDMYvD4-Dm3GgmWA-AE1UGukQiGB8BqGiaayTfhRxChyUjqietREJIzZLaEgzFTIiYpIRHjORKdZFF5u7tTVfDTgvF6axVftS0j4XQhDKWohtIG2NcxYyWdu8VHYlKZFrmfK_TLmR2bbOt6ebWQnpX2drrwWCDZA7Dz-7XNmlFDGLuRxOP-RgNHp9Ht4-yTf2C8BmhNk</recordid><startdate>200607</startdate><enddate>200607</enddate><creator>Liu, D. T. L.</creator><creator>Chan, A. Y. K.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>200607</creationdate><title>Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?</title><author>Liu, D. T. L. ; Chan, A. Y. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-ec0ad4c2e0635be2a1d7c894451e5eac41cb0630243b8121fa230670f05736fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Arthritis, Rheumatoid - complications</topic><topic>Corneal Ulcer - prevention &amp; control</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Terminology as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, D. T. L.</creatorcontrib><creatorcontrib>Chan, A. Y. K.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, D. T. L.</au><au>Chan, A. Y. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology</addtitle><date>2006-07</date><risdate>2006</risdate><volume>45</volume><issue>7</issue><spage>920</spage><epage>920</epage><pages>920-920</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><coden>BJRHDF</coden><cop>England</cop><pub>Oxford University Press</pub><pmid>16581815</pmid><doi>10.1093/rheumatology/kel059</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1462-0324
ispartof Rheumatology (Oxford, England), 2006-07, Vol.45 (7), p.920-920
issn 1462-0324
1462-0332
language eng
recordid cdi_proquest_journals_195666013
source Oxford Journals Online; Alma/SFX Local Collection
subjects Arthritis, Rheumatoid - complications
Corneal Ulcer - prevention & control
Cyclophosphamide - therapeutic use
Humans
Immunosuppressive Agents - therapeutic use
Terminology as Topic
title Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A53%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20intravenous%20cyclophosphamide%20in%20the%20prevention%20of%20corneal%20melt:%20justified%20or%20not?&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Liu,%20D.%20T.%20L.&rft.date=2006-07&rft.volume=45&rft.issue=7&rft.spage=920&rft.epage=920&rft.pages=920-920&rft.issn=1462-0324&rft.eissn=1462-0332&rft.coden=BJRHDF&rft_id=info:doi/10.1093/rheumatology/kel059&rft_dat=%3Cproquest_cross%3E1069184221%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c363t-ec0ad4c2e0635be2a1d7c894451e5eac41cb0630243b8121fa230670f05736fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=195666013&rft_id=info:pmid/16581815&rfr_iscdi=true